Fundz

Fundz Deep Dive

Everything you need to win François de Bie — in one platform.

Who to reach, what to say, and why now on François de Bie — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on François de Bie — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Emirates Biotech Appoints Marc Verbruggen As CEO and François De Bie As Chief Commercial Officer

PRIVATEAug 14, 2024almost 2 years ago

Position

Chief Commercial Officer

Company

Emirates Biotech

François de Bie
DubaiBiotechnology

Description

Emirates Biotech has appointed Marc Verbruggen as CEO, François de Bie as chief commercial officer, Aman Kulshrestha as chief technology officer, and Margrete L. Wie as head of finance. This new leadership team, based in Dubai, aims to bring expertise and vision to Emirates Biotech as the company aims to become a player in the PLA biopolymer industry.

Company Information

Company

Emirates Biotech

Location

Dubai, Dubai, United Arab Emirates

About

Emirates Biotech, based in Dubai, is a company dedicated to developing sustainable solutions in the PLA (Polylactic Acid) biopolymer industry. The company recently launched operations and aims to spearhead the production and marketing of PLA biopolymers across the Middle East, Africa, and India.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Emirates Biotech's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.